The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes.

MLA

He, Xingxing, et al. “The Association between Serum Growth Differentiation Factor 15 Levels and Lower Extremity Atherosclerotic Disease Is Independent of Body Mass Index in Type 2 Diabetes.” Cardiovascular Diabetology, vol. 19, no. 1, Mar. 2020, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12933-020-01020-9.

APA

He, X., Su, J., Ma, X., Lu, W., Zhu, W., Wang, Y., Bao, Y., & Zhou, J. (2020). The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes. Cardiovascular Diabetology, 19(1), 1–8. https://doi.org/10.1186/s12933-020-01020-9

Chicago

He, Xingxing, Jiaorong Su, Xiaojing Ma, Wei Lu, Wei Zhu, Yufei Wang, Yuqian Bao, and Jian Zhou. 2020. “The Association between Serum Growth Differentiation Factor 15 Levels and Lower Extremity Atherosclerotic Disease Is Independent of Body Mass Index in Type 2 Diabetes.” Cardiovascular Diabetology 19 (1): 1–8. doi:10.1186/s12933-020-01020-9.